StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 3.1 % Shares of PIRS stock opened at $0.17 on Friday. Pieris Pharmaceuticals has a fifty-two week low of $0.14 and […]
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 2.1 % NASDAQ PIRS opened at $0.20 on Thursday. The stock has a market capitalization of $19.42 million, a P/E ratio […]
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 186,100 shares, a drop of 26.7% from the October 15th total of 253,900 shares. Based on an average daily trading volume, of 1,710,000 shares, the short-interest […]
Connor Clark & Lunn Investment Management Ltd Sells 42,847 Shares of Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.